Patents by Inventor Katarzyna Urbanska

Katarzyna Urbanska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
    Patent number: 11912753
    Abstract: The invention provides compositions and methods for adoptive T cell therapy in treating a variety of disorders including cancer, infections, and autoimmune disorders. In one embodiment, the invention provides a universal immune receptor (UnivIR) that comprises an extracellular label binding domain, a transmembrane domain, and a cytoplasmic domain or otherwise an intracellular domain.
    Type: Grant
    Filed: June 21, 2021
    Date of Patent: February 27, 2024
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Nathalie Scholler, Katarzyna Urbanska, Daniel J. Powell, Jr.
  • METHODS AND COMPOSITIONS OF A FOLLICLE STIMULATING HORMONE RECEPTOR IMMUNORECEPTOR OR CHIMERIC ANTIGEN RECEPTOR
    Publication number: 20240052008
    Abstract: The present invention relates to compositions and methods for diagnosing and treating diseases, disorders or conditions associated with dysregulated expression of FSHR. The invention provides novel peptides that specifically bind to Follicle-stimulation hormone receptor (FSHR).
    Type: Application
    Filed: September 12, 2023
    Publication date: February 15, 2024
    Inventors: Daniel J. Powell, Caitlin Stashwick, Katarzyna Urbanska
  • Universal Immune Receptor Expressed by T Cells for the Targeting of Diverse and Multiple Antigens
    Publication number: 20210317182
    Abstract: The invention provides compositions and methods for adoptive T cell therapy in treating a variety of disorders including cancer, infections, and autoimmune disorders. In one embodiment, the invention provides a universal immune receptor (UnivIR) that comprises an extracellular label binding domain, a transmembrane domain, and a cytoplasmic domain or otherwise an intracellular domain.
    Type: Application
    Filed: June 21, 2021
    Publication date: October 14, 2021
    Inventors: Nathalie Scholler, Katarzyna Urbanska, Daniel J. Powell
  • Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
    Patent number: 11041012
    Abstract: The invention provides compositions and methods for adoptive T cell therapy in treating a variety of disorders including cancer, infections, and autoimmune disorders. In one embodiment, the invention provides a universal immune receptor (UnivIR) that comprises an extracellular label binding domain, a transmembrane domain, and a cytoplasmic domain or otherwise an intracellular domain.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: June 22, 2021
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Nathalie Scholler, Katarzyna Urbanska, Daniel J. Powell
  • METHODS AND COMPOSITIONS OF A FOLLICLE STIMULATING HORMONE RECEPTOR IMMUNORECEPTOR OR CHIMERIC ANTIGEN RECEPTOR
    Publication number: 20200199191
    Abstract: The present invention relates to compositions and methods for diagnosing and treating diseases, disorders or conditions associated with dysregulated expression of FSHR. The invention provides novel peptides that specifically bind to Follicle-stimulation hormone receptor (FSHR).
    Type: Application
    Filed: January 3, 2020
    Publication date: June 25, 2020
    Inventors: Daniel J. Powell, Jr., Caitlin Stashwick, Katarzyna Urbanska
  • Methods and compositions of a follicle stimulating hormone receptor immunoreceptor
    Patent number: 10538568
    Abstract: The present invention relates to compositions and methods for diagnosing and treating diseases, disorders or conditions associated with dysregulated expression of FSHR. The invention provides novel peptides that specifically bind to Follicle-stimulation hormone receptor (FSHR).
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: January 21, 2020
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Daniel J. Powell, Jr., Caitlin Stashwick, Katarzyna Urbanska
  • Universal Immune Receptor Expressed by T Cells for the Targeting of Diverse and Multiple Antigens
    Publication number: 20190330300
    Abstract: The invention provides compositions and methods for adoptive T cell therapy in treating a variety of disorders including cancer, infections, and autoimmune disorders. In one embodiment, the invention provides a universal immune receptor (UnivIR) that comprises an extracellular label binding domain, a transmembrane domain, and a cytoplasmic domain or otherwise an intracellular domain.
    Type: Application
    Filed: March 11, 2019
    Publication date: October 31, 2019
    Inventors: Nathalie Scholler, Katarzyna Urbanska, Daniel J. Powell
  • Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
    Patent number: 10266580
    Abstract: The invention provides compositions and methods for adoptive T cell therapy in treating a variety of disorders including cancer, infections, and autoimmune disorders. In one embodiment, the invention provides a universal immune receptor (UnivIR) that comprises an extracellular label binding domain, a transmembrane domain, and a cytoplasmic domain or otherwise an intracellular domain.
    Type: Grant
    Filed: May 10, 2017
    Date of Patent: April 23, 2019
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Nathalie Scholler, Katarzyna Urbanska, Daniel J. Powell, Jr.
  • METHODS AND COMPOSITIONS OF A FOLLICLE STIMULATING HORMONE RECEPTOR IMMUNORECEPTOR OR CHIMERIC ANTIGEN RECEPTOR
    Publication number: 20180057557
    Abstract: The present invention relates to compositions and methods for diagnosing and treating diseases, disorders or conditions associated with dysregulated expression of FSHR. The invention provides novel peptides that specifically bind to Follicle-stimulation hormone receptor (FSHR).
    Type: Application
    Filed: November 3, 2015
    Publication date: March 1, 2018
    Inventors: Daniel J. Powell, Jr., Caitlin Stashwick, Katarzyna Urbanska
  • Universal Immune Receptor Expressed by T Cells for the Targeting of Diverse and Multiple Antigens
    Publication number: 20170342124
    Abstract: The invention provides compositions and methods for adoptive T cell therapy in treating a variety of disorders including cancer, infections, and autoimmune disorders. In one embodiment, the invention provides a universal immune receptor (UnivIR) that comprises an extracellular label binding domain, a transmembrane domain, and a cytoplasmic domain or otherwise an intracellular domain.
    Type: Application
    Filed: May 10, 2017
    Publication date: November 30, 2017
    Inventors: Nathalie Scholler, Katarzyna Urbanska, Daniel J. Powell, Jr.
  • Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens
    Patent number: 9708384
    Abstract: The invention provides compositions and methods for adoptive T cell therapy in treating a variety of disorders including cancer, infections, and autoimmune disorders. In one embodiment, the invention provides a universal immune receptor (UnivIR) that comprises an extracellular label binding domain, a transmembrane domain, and a cytoplasmic domain or otherwise an intracellular domain.
    Type: Grant
    Filed: September 24, 2012
    Date of Patent: July 18, 2017
    Assignee: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventors: Nathalie Scholler, Katarzyna Urbanska, Daniel J. Powell, Jr.
  • Universal Immune Receptor Expressed by T Cells for the Targeting of Diverse and Multiple Antigens
    Publication number: 20140234348
    Abstract: The invention provides compositions and methods for adoptive T cell therapy in treating a variety of disorders including cancer, infections, and autoimmune disorders. In one embodiment, the invention provides a universal immune receptor (UnivIR) that comprises an extracellular label binding domain, a transmembrane domain, and a cytoplasmic domain or otherwise an intracellular domain.
    Type: Application
    Filed: September 24, 2012
    Publication date: August 21, 2014
    Applicant: The Trustees of the University of Pennsylvania
    Inventors: Nathalie Scholler, Katarzyna Urbanska, Daniel J. Powell, JR.